1
项与 Anti-CTLA-4 and PD-1 CAR-T cell therapy(Shanghai Cell Therapy Group Co. Ltd.) 相关的临床试验A Clinical Study of CTL-A4 and PD-1 Antibodies Expressing Mesothelin-CAR-T Cells for Patients With Mesothelin Positive Advanced Solid Tumors
This is a single-arm, open-label, one center clinical study, to determine the safety and efficacy of infusion of autologous T cells engineered to express immune checkpoint antibodies (CTLA-4 and PD-1) and chimeric antigen receptor targeting mesothelin (mesoCAR-T) in adult patients with mesothelin positive, advanced recurrent or refractory malignant solid tumors.
100 项与 Anti-CTLA-4 and PD-1 CAR-T cell therapy(Shanghai Cell Therapy Group Co. Ltd.) 相关的临床结果
100 项与 Anti-CTLA-4 and PD-1 CAR-T cell therapy(Shanghai Cell Therapy Group Co. Ltd.) 相关的转化医学
100 项与 Anti-CTLA-4 and PD-1 CAR-T cell therapy(Shanghai Cell Therapy Group Co. Ltd.) 相关的专利(医药)
100 项与 Anti-CTLA-4 and PD-1 CAR-T cell therapy(Shanghai Cell Therapy Group Co. Ltd.) 相关的药物交易